astragaloside a has been researched along with Adjuvant Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MZ; Wang, B | 1 |
| Lv, CY; Wang, CY; Wang, YZ; Xu, H; Zhang, HN | 1 |
2 other study(ies) available for astragaloside a and Adjuvant Arthritis
| Article | Year |
|---|---|
Astragaloside IV possesses antiarthritic effect by preventing interleukin 1β-induced joint inflammation and cartilage damage.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Cartilage; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Interleukin-1beta; Male; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2014 |
Astragaloside IV suppresses inflammatory mediator production in synoviocytes and collagen‑induced arthritic rats.
Topics: Animals; Arthritis, Experimental; Cell Proliferation; Cells, Cultured; Collagen Type II; Cyclooxygenase 2; Cytokines; Down-Regulation; HMGB1 Protein; Inflammation Mediators; Intercellular Adhesion Molecule-1; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Male; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Saponins; Synoviocytes; Triterpenes | 2016 |